Franklin Resources Inc. Has $34.88 Million Stock Position in GE HealthCare Technologies Inc. $GEHC

Franklin Resources Inc. boosted its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 3.6% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 470,904 shares of the company’s stock after purchasing an additional 16,183 shares during the quarter. Franklin Resources Inc. owned about 0.10% of GE HealthCare Technologies worth $34,880,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. N.E.W. Advisory Services LLC acquired a new stake in shares of GE HealthCare Technologies during the 1st quarter worth approximately $25,000. Allianz SE lifted its position in shares of GE HealthCare Technologies by 165.2% during the 2nd quarter. Allianz SE now owns 350 shares of the company’s stock valued at $26,000 after acquiring an additional 218 shares during the period. Gladwyn Financial Advisors Inc. bought a new position in GE HealthCare Technologies during the second quarter worth $34,000. Game Plan Financial Advisors LLC boosted its stake in GE HealthCare Technologies by 295.3% during the second quarter. Game Plan Financial Advisors LLC now owns 502 shares of the company’s stock worth $37,000 after acquiring an additional 375 shares in the last quarter. Finally, Zions Bancorporation National Association UT acquired a new stake in GE HealthCare Technologies in the first quarter worth $42,000. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Trading Up 0.8%

GEHC opened at $80.63 on Thursday. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The firm has a market capitalization of $36.73 billion, a PE ratio of 16.66, a P/E/G ratio of 3.34 and a beta of 1.13. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.18 and a quick ratio of 0.95. The company’s 50-day moving average is $74.84 and its 200 day moving average is $74.07.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, topping analysts’ consensus estimates of $1.05 by $0.02. The firm had revenue of $5.14 billion during the quarter, compared to analyst estimates of $5.07 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The company’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period in the previous year, the company posted $1.14 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. As a group, research analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Friday, January 9th will be given a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, January 9th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 2.89%.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the stock. Zacks Research lowered shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, September 29th. Wall Street Zen lowered GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, September 20th. Evercore ISI upped their price target on GE HealthCare Technologies from $88.00 to $92.00 and gave the stock an “outperform” rating in a research note on Thursday, October 30th. Citigroup lowered GE HealthCare Technologies from a “buy” rating to a “neutral” rating and cut their price target for the stock from $93.00 to $83.00 in a report on Tuesday, October 7th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Monday, November 17th. Six equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $86.45.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.